Qiming-Backed AI Drug Discovery Startup Insilico Medicine Files For Hong Kong IPO
- Thursday, June 29, 2023, 7:10
- Market
- Add a comment
Insilico Medicine was valued at about $895 million after raising $95 million last July from the likes of leading Chinese healthcare-focused firm Qiming Venture Partners and billionaire Eduardo Saverin’s B Capital, among others.
About the Author
admin123 has written 23404 stories on this site.
